Stocks and InvestingStocks and Investing
Thu, October 28, 2021
Wed, October 27, 2021
Tue, October 26, 2021
Mon, October 25, 2021

Raghuram Selvaraju Maintained (BBIO) at Strong Buy with Increased Target to $88 on, Oct 25th, 2021


Published on 2024-10-27 18:19:07 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "BridgeBio Pharma, Inc." (BBIO) at Strong Buy with Increased Target from $87 to $88 on, Oct 25th, 2021.

Raghuram has made no other calls on BBIO in the last 4 months.



There are 2 other peers that have a rating on BBIO. Out of the 2 peers that are also analyzing BBIO, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Raghuram


  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Increased Target to $68 on, Monday, October 4th, 2021
  • Geoff Meacham of "B of A Securities" Upgraded from Hold to Strong Buy and Held Target at $75 on, Friday, September 10th, 2021